BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
3041 – 3050 of 3086
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
- Contribution to journal › Article
-
Mark
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
- Contribution to journal › Article
-
Mark
Zoom-in array comparative genomic hybridization (aCGH) to detect germline rearrangements in cancer susceptibility genes.
- Contribution to journal › Article
-
Mark
Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples.
- Contribution to journal › Article
-
Mark
Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome.
- Contribution to journal › Article
-
Mark
Generation of trisomies in cancer cells by multipolar mitosis and incomplete cytokinesis.
- Contribution to journal › Article
-
Mark
Cystatins - Extra- and Intracellular Cysteine Protease Inhibitors: High-level Secretion and Uptake of Cystatin C in Human Neuroblastoma Cells.
- Contribution to journal › Article
-
Mark
Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2.
- Contribution to journal › Article
-
Mark
Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells.
- Contribution to journal › Article
-
Mark
Young age at diagnosis is a risk factor for negative late socio-economic effects after acute lymphoblastic leukemia in childhood.
- Contribution to journal › Article
